Sign Up

    BLFE

    COM:BIOLIFESCIENCES

    BioLife Sciences

    • Stock

    USD

    Last Close

    0.00

    31/03 20:00

    Market Cap

    118

    Beta: -

    Volume Today

    50

    Avg: -

    OverviewMetricsFinancialsAPI
    Income StatementBalance SheetCash FlowKey MetricsRatios
    Quarterly
    Yearly

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Feb '21
    May '21
    Aug '21
    Feb '22
    Aug '22
    Nov '22
    Feb '23
    May '23
    Aug '23
    net income
    -67.36K
    -
    -137.76K
    104.51%
    -143.16K
    3.93%
    -132.05
    99.91%
    depreciation and amortization
    deferred income tax
    stock based compensation
    27.09
    -
    49.85
    -
    change in working capital
    -5.64K
    -
    62.75K
    1,212.54%
    82.80K
    31.96%
    accounts receivables
    inventory
    -23.52
    -
    accounts payables
    17.88K
    -
    63.07K
    252.78%
    82.88K
    31.40%
    other working capital
    -23.52K
    -
    -326
    98.61%
    -80
    75.46%
    other non cash items
    9.21K
    -
    -27.28K
    396.24%
    -33.23K
    21.82%
    80.24
    100.24%
    net cash provided by operating activities
    -45.91K
    -
    -39.21K
    14.59%
    -10.71K
    72.68%
    -1.96
    99.98%
    investments in property plant and equipment
    acquisitions net
    purchases of investments
    sales maturities of investments
    other investing activites
    net cash used for investing activites
    debt repayment
    -75K
    -
    common stock issued
    common stock repurchased
    dividends paid
    other financing activites
    75
    -
    net cash used provided by financing activities
    75K
    -
    effect of forex changes on cash
    12.05
    -
    0.50
    -
    net change in cash
    29.10K
    -
    -39.21K
    234.76%
    -10.71K
    72.68%
    -1.46
    99.99%
    cash at beginning of period
    46.77K
    -
    79.51K
    69.98%
    40.29K
    49.32%
    17.08
    99.96%
    cash at end of period
    75.88K
    -
    40.29K
    46.90%
    29.58K
    26.59%
    15.62
    99.95%
    operating cash flow
    -45.91K
    -
    -39.21K
    14.59%
    -10.71K
    72.68%
    -1.96
    99.98%
    capital expenditure
    free cash flow
    -45.91K
    -
    -39.21K
    14.59%
    -10.71K
    72.68%
    -1.96
    99.98%

    All numbers in USD (except ratios and percentages)